Search filters

List of works by Nigel Rawson

"Cost-effectiveness" estimates result in flawed decision-making in listing drugs for reimbursement.

scientific article

"Effectiveness" in the evaluation of new drugs: a misunderstood concept?

scientific article published on 01 January 2001

25 years of pharmacoepidemiologic innovation: the Saskatchewan health administrative databases.

scientific article published on 2 May 2011

A national drug agency.

scientific article published on April 2003

Adjuvant chemotherapy in head and neck cancer

scientific article published on 01 May 1990

Assessing prescription medications for priority regulatory review.

scientific article

Canada's Adverse Drug Reaction Reporting System: A Failing Grade

scientific article

Canadian and US Drug Approval Times and Safety Considerations

scientific article published on October 1, 2003

Commentary: Canadian Association for Population Therapeutics: the past, present and future - a personal viewpoint and a call to action.

scientific article published on 16 August 2011

Comparative-study of intramuscular ketorolac tromethamine and morphine in patients experiencing cancer pain

scientific article published on 01 June 1995

Computerisation of urothelial carcinoma records: 16 years' experience with the TNM system

scientific article published on 01 June 1990

Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations

scientific article published on 01 September 2000

Could conditional release of new drugs provide the information required to study drug effectiveness? - A discussion paper

scientific article published on 01 January 2000

Cutting costs by targeting prescribing practices.

scientific article

Deafness with enalapril and prescription event monitoring

scientific article published on 01 April 1987

Differences in relapse precipitants and coping behaviour between alcohol relapsers and survivors

scientific article published on January 1, 1979

Discrepancies in immunization records

scientific article published on 01 August 1980

Distribution of drug-related problems among London casualty departments

scientific article published on May 1, 1978

Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?

scientific article published on 22 November 2017

Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions

scientific article published on 01 January 2006

Drug Points: Angio-oedema and urticaria associated with enalapril.

scientific article

Drug approval times.

scientific article

Drug safety: withdrawn medications are only part of the picture

scientific article published on 13 February 2016

Epidemiology in the pharmaceutical Industry: A Canadian perspective

scientific article published on 01 October 2006

Erythromycin estolate and jaundice.

scientific article

Estrogen and progesterone receptors in the normal female breast

scientific article published on 01 April 1991

Health Canada's use of priority review status for drugs for unmet needs

scientific article published on 07 August 2015

Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost

scientific article published on 23 March 2017

Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial

scientific article published on 01 September 2018

Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.

scientific article published in December 1998

IMMUNIZATION RECORDS

scientific article published in February 1981

Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapy.

scientific article published in July 1995

Importation of drugs into the United States from Canada.

scientific article published in June 2017

Issues in the approval of, access to, and post-marketing follow-up of new drugs in Canada: a personal viewpoint.

scientific article

Letter to the ISPE commentary editor

scientific article published on 01 January 2003

National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"

scientific article published on 01 January 2020

Need for an improved submission process for listing drugs for reimbursement in Canadian provinces.

scientific article published on January 2003

New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.

scientific article

New drug approval times and safety warnings in the United States and Canada, 1992-2011

scientific article published on April 22, 2013

Opiate use and legislative control: a nineteenth century case study

scientific article published on May 1, 1979

Peptic ulcer and piroxicam

scientific article published in the British Medical Journal

Plus ça change, plus c'est la même chose

scientific article published on 01 November 1991

Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring

scientific article

Prescription-Event Monitoring. Recent experience with 5 NSAIDs

scientific article published on 01 January 1986

Prescription-event monitoring of 10,895 patients treated with alprazolam.

scientific article published in March 1991

Prescription-event monitoring: methodology and recent progress

scientific article published on 01 January 1990

Promoting adherence to medicines: possible lessons for Canada?

scientific article published on 20 November 2017

Reliability of the recording of hysterectomy in the Saskatchewan health care system.

scientific article published on September 1996

Respiratory infection and otitis media visits in relation to pneumococcal conjugate vaccine use in Saskatchewan

scientific article published on January 2013

Review of the quality of observational studies of the association between rosiglitazone and acute myocardial infarction

scientific article published on 02 June 2014

Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010.

scientific article

Sedative-hypnotic drug use in Canada.

scientific article published in January 1991

Serum markers for primary and recurrent breast cancer: BCM-EIA, CAM 26 and CAM 29

scientific article published on 01 January 1992

Side-effects of benoxaprofen

scientific article published on 01 December 1984

The aging Canadian population and hospitalizations for acute myocardial infarction: projection to 2020.

scientific article

The aging male population and medical care for benign prostatic hyperplasia in Canada

scientific article

Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998.

scientific article

Unlocking datasets

scientific article published on 01 January 1994

Use of personal records for research purposes. Identification numbers help maintain confidentiality.

scientific article published on January 1995

What Does the New Ontario Pharmacare Plan offer Children and Young Adults with Rare Disorders?

scientific article published in December 2017